GB1567547A - Fission product of rabies virus process for its preparation and vaccine containing same - Google Patents

Fission product of rabies virus process for its preparation and vaccine containing same Download PDF

Info

Publication number
GB1567547A
GB1567547A GB5495/77A GB549577A GB1567547A GB 1567547 A GB1567547 A GB 1567547A GB 5495/77 A GB5495/77 A GB 5495/77A GB 549577 A GB549577 A GB 549577A GB 1567547 A GB1567547 A GB 1567547A
Authority
GB
United Kingdom
Prior art keywords
fraction
rabies virus
gradient
vaccine
fission
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5495/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of GB1567547A publication Critical patent/GB1567547A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GB5495/77A 1976-02-12 1977-02-10 Fission product of rabies virus process for its preparation and vaccine containing same Expired GB1567547A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2605469A DE2605469C3 (de) 1976-02-12 1976-02-12 Verfahren zur Gewinnung eines Spaltprodukts des Tollwut-Virus und dieses enthaltender Impfstoff

Publications (1)

Publication Number Publication Date
GB1567547A true GB1567547A (en) 1980-05-14

Family

ID=5969649

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5495/77A Expired GB1567547A (en) 1976-02-12 1977-02-10 Fission product of rabies virus process for its preparation and vaccine containing same

Country Status (15)

Country Link
JP (1) JPS5299209A (https=)
AT (1) AT350715B (https=)
BE (1) BE851404A (https=)
CA (1) CA1087982A (https=)
CH (1) CH638562A5 (https=)
DE (1) DE2605469C3 (https=)
DK (1) DK145580C (https=)
FR (1) FR2340955A1 (https=)
GB (1) GB1567547A (https=)
IE (1) IE44440B1 (https=)
IL (1) IL51412A (https=)
IT (1) IT1075115B (https=)
LU (1) LU76737A1 (https=)
NL (1) NL7701255A (https=)
OA (1) OA05567A (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12258540B2 (en) 2017-10-30 2025-03-25 Takeda Pharmaceutical Company Limited Environmentally compatible detergents for inactivation of lipid-enveloped viruses

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3070388D1 (en) * 1980-10-02 1985-05-02 Schering Corp Injectable rabies vaccine composition and method for preparing same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12258540B2 (en) 2017-10-30 2025-03-25 Takeda Pharmaceutical Company Limited Environmentally compatible detergents for inactivation of lipid-enveloped viruses

Also Published As

Publication number Publication date
DK145580C (da) 1983-05-16
OA05567A (fr) 1981-04-30
ATA92877A (de) 1978-11-15
IT1075115B (it) 1985-04-22
BE851404A (fr) 1977-08-16
CH638562A5 (en) 1983-09-30
DK145580B (da) 1982-12-13
DE2605469A1 (de) 1977-09-15
CA1087982A (en) 1980-10-21
DE2605469C3 (de) 1980-04-10
FR2340955B1 (https=) 1979-03-02
JPS5299209A (en) 1977-08-19
IE44440L (en) 1977-08-12
AT350715B (de) 1979-06-11
DE2605469B2 (de) 1979-08-02
IL51412A0 (en) 1977-04-29
FR2340955A1 (fr) 1977-09-09
DK59377A (da) 1977-08-13
IL51412A (en) 1980-05-30
NL7701255A (nl) 1977-08-16
LU76737A1 (https=) 1977-08-19
IE44440B1 (en) 1981-12-02

Similar Documents

Publication Publication Date Title
Gottlieb et al. Identification and partial characterization of an extracellular acid phosphatase activity of Leishmania donovani promastigotes
EP0171086B1 (en) A method for purification of influenza virus
IE832394L (en) Immunogenic protein or peptide complex vaccine.
EP0009872A1 (en) Antigen preparation, process for producing it and pharmacological or dental preparations containing the antigen preparation or antibodies thereto
WO1993014196A1 (fr) Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie
US6893639B2 (en) Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
FI72653C (fi) Foerfarande foer framstaellning av ett faktor viii(ahf)-koncentrat.
JPH0463863B2 (https=)
HU217582B (hu) Streptococcus B csoportba tartozó törzsek elleni immunitást biztosító, Rib fehérjenevű felületi protein, eljárás a protein tisztítására, reagenskészlet és gyógyszerkészítmény
DE69330778T2 (de) Vogel-mycoplasmaantigen, sein gen, das gen enthaltender rekombinanter vektor, und damit hergestellter impfstoff
US4220638A (en) Antigenic complex from N. Gonorrhoeae
GB1567547A (en) Fission product of rabies virus process for its preparation and vaccine containing same
DE69130724T2 (de) Verfahren zur Gewinnung von rekombinantem Hepatitis B Virus (HEP B) Oberflächeantigen
György et al. Release of envelope glycoprotein from rabies virions by a nonionic detergent
Cox et al. Preparation and characterization of rabies virus hemagglutinin
US3953290A (en) Polypeptides as vitro active cell growth enhancing factors and methods of use
DE3933850A1 (de) Zytolyse-inhibitor (zli), eine diese blutplasmaprotein kodierende dna-sequenz, sowie ein plasmid, ein wirtsorganismus und ein verfahren zur gewinnung dieses proteins
RU97108362A (ru) Главный белок cd внешней мембраны moraxella
EP0381427B1 (en) Vaccine Composition
US5650154A (en) Protective antigens against disease pathogens
Pang et al. Cardiac sarcolemma of the hamster. Enrichment of the (Na++ K+)-ATPase
EP0247881B1 (en) Process for culturing animal cells and appropriate media
Hashimoto et al. Isolation of the structural proteins of western equine encephalitis virus by isoelectric focusing
Howell et al. Cloning and expression of Taenia ovis antigens in Escherichia coli
EP0002645B1 (en) Antigenic complex from neisseria gonorrhoeae, process and vaccine

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee